Gift Opening
$200 Off MarketBeat All Access
Thanks for being one of our best subscribers! You are eligible for a limited-time discount.
  •  days
  •  Hours
  •  Minutes
  •  Seconds
Claim Your Discount
×
Free Trial
Thank you for registering! Take a moment to confirm your subscription to Insider Trades Newsletter so that you can access MarketBeat's tools, reports, and news. Please click the "Send Confirmation Email" button and we'll send you an email with confirmation instructions.

The 12 Most-Hated Stocks on Wall Street - 4 of 12

 
 

Starbucks (NASDAQ:SBUX)

Number of Downgrades
24 (in the last 90 days)
Consensus Rating
Hold
Rating Score
2.4
Ratings Breakdown
9 Buy Ratings, 16 Hold Ratings, 0 Sell Ratings.
Consensus Price Target
$96.43 (24.2% Upside)

About Starbucks

Starbucks logoStarbucks Corporation, together with its subsidiaries, operates as a roaster, marketer, and retailer of coffee worldwide. The company operates through three segments: North America, International, and Channel Development. Its stores offer coffee and tea beverages, roasted whole beans and ground coffees, single serve products, and ready-to-drink beverages; and various food products, such as pastries, breakfast sandwiches, and lunch items. Read More 
 

Recent Analyst Ratings

DateBrokerageActionRatingPrice TargetDetails
5/6/2024Piper SandlerLower Price TargetNeutral ➝ Neutral$88.00 ➝ $85.00
5/3/2024HSBCLower Price TargetHold ➝ Hold$107.00 ➝ $84.00
5/3/2024DZ BankDowngradeBuy ➝ Hold$75.00
5/1/2024JPMorgan Chase & Co.Lower Price TargetOverweight ➝ Overweight$100.00 ➝ $92.00
5/1/2024CitigroupLower Price TargetNeutral ➝ Neutral$95.00 ➝ $85.00
5/1/2024UBS GroupLower Price TargetNeutral ➝ Neutral$95.00 ➝ $85.00
5/1/2024Wells Fargo & CompanyLower Price TargetOverweight ➝ Overweight$105.00 ➝ $90.00
5/1/2024Evercore ISILower Price TargetOutperform ➝ Outperform$120.00 ➝ $92.00
5/1/2024Jefferies Financial GroupLower Price TargetHold ➝ Hold$94.00 ➝ $84.00
5/1/2024Stifel NicolausLower Price TargetHold ➝ Hold$90.00 ➝ $80.00
 

**Breaking News** LIttle Known Biotech Company Does $41 Million In Q1! (Ad)

Learn more about why Zack’s has increased its price target on this company to a whopping $23.25!

Click for Zack's full report